Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Explore Visa cards that provide rewards without the burden of annual fees. Enjoy benefits while saving money.
21,871 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Home Depot’s stock surge followed a better-than-expected quarterly showing, with comps rising and margins improving. ...
Brisk advances in speed, stealth, and digital systems are forcing defense forces to overhaul how pilots are trained, ...
Investors who want clarity from SPX Technologies can decode the SPXC earnings transcript. This guide translates the n...
Private builders face heightened competition from public homebuilders in 2026. A new IBS session maps a practical pri...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Snowflake delivered strong Q4 revenue but faces securities lawsuits and an looming April 27 deadline, creating a mixe...
A major hedge fund recently boosted its Garrett Motion position, highlighting how hybrid powertrain trends are reshap...
Micron Technology soared 326% in just 12 months, but a sky-high gain doesn’t guarantee a smart buy. This guide breaks...
A U.S. military laser downed a drone near the border, later identified as a CBP asset. Lawmakers blast the handling, ...
As geopolitical shocks ripple through energy markets, OPEC+ debates whether to push a bigger production increase beyo...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...